MarketBeat on MSN5d
Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are CrucialDetailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...
Eli Lilly & Co.’s full-year earnings forecast came in line with analysts’ estimates as the company works to fix inventory ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.
On Monday, Eli Lilly And Co (NYSE:LLY) inked two strategic collaborations to expand radiopharmaceuticals and metabolic-associated steatohepatitis (MASH), respectively. AdvanCell announced that it ...
February 11, 2025, 06:09 AM ET, BY Christie, Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback